Blog

Samer Al Hadidi: Second primary malignancies after tandem autologous hematopoietic stem cell transplantation for multiple myeloma

Photo from Samer Al Hadidi/X

Aug 11, 2024, 19:32

Samer Al Hadidi: Second primary malignancies after tandem autologous hematopoietic stem cell transplantation for multiple myeloma

Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, posted on X about recent paper as first author, titled “Second primary malignancies after tandem autologous hematopoietic stem cell transplantation for multiple myeloma” published on Wiley Online Library.

Authors: Samer Al Hadidi, Obada Ababneh, Carolina Schinke, Sharmilan Thanendrarajan, Clyde Bailey, Guido Tricot, John Shaughnessy Jr, Fenghuang Zhan, Jeffrey Sawyer, Eric R. Siegel, Maurizio Zangari, Bart Barlogie, Frits van Rhee

“Check our recent paper UAMS Myeloma Center, The American Journal of Hematology: Second primary malignancies after tandem autologous hematopoietic stem cell transplantation for multiple myeloma.

n=1379
Median FU:16.6 years
SHM:5.6% (1 vs 2 transplants=no difference).”

Source: Samer Al Hadidi/X

Bart Barlogie cancer Carolina Schinke Clyde Bailey Eric R. Siegel Fenghuang Zhan Frits Van Rhee Guido Tricot Jeffrey Sawyer John Shaughnessy Jr Maurizio Zangari multiple myeloma Obada Ababneh OncoDaily Oncology Samer Al Hadidi Sharmilan Thanendrarajan The American Journal of Hematology UAMS Myeloma Center Wiley Online Library

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage